| Structural and mechanistic bases for a potent HIV-1 capsid inhibitor SM Bester, G Wei, H Zhao, D Adu-Ampratwum, N Iqbal, VV Courouble, ... Science 370 (6514), 360-364, 2020 | 152 | 2020 |
| Structural insights of stereospecific inhibition of human acetylcholinesterase by VX and subsequent reactivation by HI-6 SM Bester, MA Guelta, J Cheung, MD Winemiller, SY Bae, J Myslinski, ... Chemical research in toxicology 31 (12), 1405-1417, 2018 | 44 | 2018 |
| Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection G Wei, N Iqbal, VV Courouble, AC Francis, PK Singh, A Hudait, ... Nature Communications 13 (1), 5879, 2022 | 22 | 2022 |
| Structural and mechanistic bases of viral resistance to HIV-1 capsid inhibitor lenacapavir SM Bester, D Adu-Ampratwum, AS Annamalai, G Wei, L Briganti, ... Mbio 13 (5), e01804-22, 2022 | 15 | 2022 |
| Insights into the porcine reproductive and respiratory syndrome virus viral ovarian tumor domain protease specificity for ubiquitin and interferon stimulated gene product 15 SM Bester, CM Daczkowski, KS Faaberg, SD Pegan ACS infectious diseases 4 (9), 1316-1326, 2018 | 11 | 2018 |
| Structural and biochemical insights into the inhibition of human acetylcholinesterase by G-series nerve agents and subsequent reactivation by HI-6 JR McGuire, SM Bester, MA Guelta, J Cheung, C Langley, MD Winemiller, ... Chemical Research in Toxicology 34 (3), 804-816, 2021 | 10 | 2021 |
| The structural and biochemical impacts of monomerizing human acetylcholinesterase SM Bester, KA Adipietro, VL Funk, JM Myslinski, ND Keul, J Cheung, ... Protein Science 28 (6), 1106-1114, 2019 | 10 | 2019 |
| Synthesis and Molecular Properties of Nerve Agent Reactivator HLö-7 Dimethanesulfonate FL Hsu, SY Bae, J McGuire, DR Anderson, SM Bester, JJ Height, ... ACS Medicinal Chemistry Letters 10 (5), 761-766, 2019 | 7 | 2019 |
| Crystal structure of the GDP-bound human M-RAS protein in two crystal forms SM Bester, R Abrahamsen, L Rodrigues Samora, WI Wu, TC Mou Structural Biology and Crystallization Communications 80 (9), 220-227, 2024 | | 2024 |
| Enhancing the apo protein tyrosine phosphatase non-receptor type 2 crystal soaking strategy through inhibitor-accessible binding sites SM Bester, R Linwood, R Kataoka, WI Wu, TC Mou Structural Biology and Crystallization Communications 80 (9), 2024 | | 2024 |
Scott PeganUniversity of California Riverside School of Medicine在 medsch.ucr.edu 的电子邮件经过验证
